Oscar Health’s Stock Gets a Second Look—What’s Behind the Buzz?
Oscar Health, a company focused on health insurance under the Affordable Care Act, just got a boost from Barclays. The bank’s analyst upgraded its stock to “Overweight” and set a price target of $35, suggesting shares could jump another 25% soon. That’s a big deal because Oscar’s stock is already up